Streetbeat News

Stock Prices

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for April 15th, 2024, provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula considering price, volume, and options flow. It offers detailed analysis for each asset, suggesting potential movements and targets for both bullish and bearish scenarios. Additionally, the memo highlights the importance of monitoring economic data releases and geopolitical developments for their potential impact on the market.

Portfolio Pulse from RIPS

April 15, 2024 | 2:23 pm

AAPL

Apple Inc. has responded to Epic Games' lawsuit by denying allegations of violating a court order related to its App Store, accusing Epic Games of trying to increase its profitability by forcing Apple to offer its development tools for free. The legal battle, initiated by Epic Games in 2020 over antitrust claims against Apple's app download and in-app transaction controls, continues as Apple refutes Epic's claims and requests a federal judge to dismiss the contempt charges.

Portfolio Pulse from Rounak Jain

April 15, 2024 | 2:23 pm

CRM

INFA

Informatica shares are trading lower due to increased volatility after reports emerged that Salesforce is in discussions to acquire the company.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 2:20 pm

NMRA

Neumora Therapeutics Inc (NASDAQ:NMRA) shares dropped after the FDA placed a clinical hold on its Phase 1 trial of NMRA-266, a drug for neurological conditions, due to preclinical data showing convulsions in rabbits. The company is in discussions with the FDA to resolve the issue. Neumora's stock fell 14.9% to $11.54.

Portfolio Pulse from Vandana Singh

April 15, 2024 | 2:17 pm

MPW

Medical Properties Trust, Inc. (MPW) shares rose after selling its majority interest in five Utah hospitals, retaining a 25% stake in a new joint venture. The deal provided MPW with $1.1 billion in cash, expected to reduce debt and pay off a $300 million loan. MPW also declared a quarterly dividend of $0.15 per share. Analysts have mixed views on MPW, with a 1-year price target averaging $4.38, indicating a potential downside.

Portfolio Pulse from Erica Kollmann

April 15, 2024 | 2:15 pm

QCOM

Qualcomm's (NYSE:QCOM) short interest has decreased by 3.87%, with 19.41 million shares sold short, representing 1.74% of its float. This decrease suggests a more bullish sentiment among investors compared to its peers, where the average short interest is 4.41%. Short interest is a key indicator of market sentiment, and a decline may not directly imply a stock price increase but indicates fewer shares are being shorted.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 2:15 pm

CCK

Crown Holdings (NYSE:CCK) has seen a decrease in short interest, now at 2.74 million shares or 2.41% of float, indicating a potential shift in market sentiment towards the stock. The short interest decline suggests investors may be becoming more bullish on CCK, contrasting with the peer group average of 2.73% short interest.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 2:15 pm

NRXP

NRX Pharmaceuticals (NYSE:NRXP) has seen a significant increase in short interest, with the short percent of float rising 987.89% to 62.88% of all shares available for trading. This indicates a bearish market sentiment towards NRXP, as more traders are betting against the stock. However, an increase in short interest can sometimes be bullish, suggesting a potential for a short squeeze if the stock price starts to rise. NRXP's short interest is notably higher than its peer group average of 3.23%.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 2:15 pm

RDDT

Reddit Inc (NYSE:RDDT) has received varied analyst ratings and price targets following its IPO last month, the first major IPO of 2024. Analysts from Morgan Stanley, JMP Securities, Piper Sandler, Roth MKM, JPMorgan, and Needham have initiated coverage with ratings ranging from Equal-Weight to Buy and price targets between $45 and $55. Reddit's shares were down 3.12% at $40.95 at the time of publication. The company is set to report its first quarterly financial results as a public company on May 7.

Portfolio Pulse from Adam Eckert

April 15, 2024 | 2:13 pm

MRNS

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) stock hit a 52-week low after announcing the continuation of the Phase 3 RAISE trial for IV ganaxolone in treating refractory status epilepticus, with results expected in summer 2024. The company remains committed to its development plans, including the Phase 3 TrustTSC trial for Ztalmy, with topline results due in Q4 2024. Preliminary Q1 2024 revenue is between $7.4 and $7.6 million, with cash reserves of $113.3 million. Cost reduction strategies are being evaluated to extend the cash runway.

Portfolio Pulse from Vandana Singh

April 15, 2024 | 2:13 pm